Patent protections for Software as a Medical Device are increasingly important due to the additional investments in clinical evaluation that may be needed to withstand the FDA scrutiny under the new draft guidelines.
Exhibitors Inquiries:
Linc Cai
Tel: +86 21 6157 7217
Email: [email protected]
Conference Inquiries:
Rebecca Lv
Tel：+86-21 6157 7279
Email：[email protected]
Visitors Inquiry & Media Cooperation:
Tracy Zhang
Tel： +86 10 6562 3307
Email：[email protected]
X
